Stockreport

Pluri Announces Expansion of Intellectual Property Portfolio with Two Granted Patents for 3D Expansion of Immune Cells in the United States and Israel [Yahoo! Finance]

Pluri Inc.  (PLUR) 
PDF Pluri's MAIT platform enable s commercial scale production of powerful immune cells as a potential first-in-class, ready to use, “ off-the-shelf ” therapy for cancer pa [Read more]